6 Hepatitis C Article Summaries and Links

[Guest guest]

Asia's problem with chronic hepatitis

Examiner.com

With over 500 million people on the globe afflicted with chronic hepatitis, it

far outpaces either cancer or HIV worldwide. In fact, one in 12 people on the

planet are chronically infected with either hepatitis B or C, causing the

creation of the World ...

See all stories on this topic »

Report: Desmond Wolfe's Medical Issue Revealed

Wrestling Inc.

By | April 24, 2011 | Comments Randy Ricci, a former production

manager for TNA Wrestling, claimed in a blog post on Friday that the reason

Desmond Wolfe has not been wrestling in recent months is because he has

Hepatitis C—a viral disease ...

See all stories on this topic »

On the long, hard road to a breakthrough

Boston Globe

(Josh Reynolds for The Boston Globe) By Carolyn Y. CAMBRIDGE — Fifteen

years ago, Boger received a call from a team of scientists one floor down

at Vertex Pharmaceuticals Inc. who were searching for the key to hepatitis C,

....

See all stories on this topic »

Boston Globe

Lifeline Direct Insurance Assists Clients with Pre Existing Conditions

San Francisco Chronicle (press release)

These types of conditions in the past-Diabetes Type 1 and 2, Hepatitis, Sleep

Apnea, Epilepsy, etc.-would have at best slowed the process down by days or

weeks and at worst would have prevented these individuals from getting term life

insurance at all. ...

See all stories on this topic »

The Ticker

Boston Herald

Both Cambridge's Vertex Pharmaceuticals and New Jersey-based Merck & Co. are

seeking to gain federal approval soon for drugs to treat hepatitis C. These

competing drugs would be the first therapies in almost a decade to win US

clearance for the ...

See all stories on this topic »

Now comes the hard part: marketing an unknown

Boston Globe

He does admit it was a gamble to trade Merck & Co. for Vertex — and uproot his

family — before telaprevir, Vertex's potential blockbuster drug to treat

hepatitis C, has won approval from regulators. “There's some risk from a career

perspective,'' ...

See all stories on this topic »